Cryoballoon Ablation for Pulmonary Vein Isolation in Patients with Persistent Atrial Fibrillation

Circulation: Arrhythmia and Electrophysiology

Volumn 8, Issue 5, 2015, Pages 1073-1079

  Koektuerk, Buelent ^a   Yorgun, Hikmet ^a   Hengeoez, Oezlem ^b   Turan, Cem H ^a   Dahmen, Alina ^a   Yang, Alexander ^a   Bansmann, Paul M ^a   Gorr, Eduard ^a   Hoppe, Christian ^a   Turan, Ramazan G ^a   Horlitz, Marc ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b Institute of Pathology   (Germany)

Author keywords

cryoballoon ablation; persistent atrial fibrillation; pulmonary vein isolation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLECAINIDE; PROPAFENONE;

ABLATION THERAPY; ADULT; ANEURYSM; ARTICLE; ATRIAL FIBRILLATION; CONFIDENCE INTERVAL; CRYOBALLOON ABLATION; FALSE ANEURYSM; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART TAMPONADE; HEMATOMA; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PERICARDIAL EFFUSION; PERSISTENT ATRIAL FIBRILLATION; PHRENIC NERVE PARALYSIS; PRIORITY JOURNAL; PULMONARY VEIN; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; REGRESSION ANALYSIS; TRANSTHORACIC ECHOCARDIOGRAPHY; CRYOSURGERY; DEVICES; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CRYOSURGERY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PULMONARY VEINS; TREATMENT OUTCOME;

EID: 84944686815     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.115.002776     Document Type: Article

References (17)

1. Kuck KH, Fürnkranz A. Cryoballoon ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21:1427-1431. doi: 10.1111/j.1540-8167.2010.01944.x.
2. Metzner A, Reissmann B, Rausch P, Mathew S, Wohlmuth P, Tilz R, Rillig A, Lemes C, Deiss S, Heeger C, Kamioka M, Lin T, Ouyang F, Kuck KH, Wissner E. One-year clinical outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Circ Arrhythm Electrophysiol. 2014;7:288-292. doi: 10.1161/CIRCEP.114.001473.
3. Aytemir K, Gurses KM, Yalcin MU, Kocyigit D, Dural M, Evranos B, Yorgun H, Ates AH, Sahiner ML, Kaya EB, Oto MA. Safety and efficacy outcomes in patients undergoing pulmonary vein isolation with secondgeneration cryoballoon. Europace. 2015;17:379-387. doi: 10.1093/europace/euu273.
4. Fürnkranz A, Bordignon S, Schmidt B, Gunawardene M, Schulte-Hahn B, Urban V, Bode F, Nowak B, Chun JK. Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon. J Cardiovasc Electrophysiol. 2013;24:492-497. doi: 10.1111/jce.12082.
5. Di Giovanni G, Wauters K, Chierchia GB, Sieira J, Levinstein M, Conte G, de Asmundis C, Baltogiannis G, Saitoh Y, Ciconte G, Julia J, Mugnai G, Irfan G, Brugada P. One-year follow-up after single procedure Cryoballoon ablation: a comparison between the first and second generation balloon. J Cardiovasc Electrophysiol. 2014;25:834-839. doi: 10.1111/jce.12409.
6. Ciconte G, Ottaviano L, de Asmundis C, Baltogiannis G, Conte G, Sieira J, Di Giovanni G, Saitoh Y, Irfan G, Mugnai G, Storti C, Montenero AS, Chierchia GB, Brugada P. Pulmonary vein isolation as index procedure for persistent atrial fibrillation: One-year clinical outcome after ablation using the second-generation cryoballoon. Heart Rhythm. 2015;12:60-66. doi: 10.1016/j.hrthm.2014.09.063.
7. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ, Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14:528-606. doi: 10.1093/europace/eus027.
8. Hosmer DW, Lemeshow, S, Sturdivant RX. Applied Logistic Regression. New York: Wiley, 2013;89-94.
9. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659-666. doi: 10.1056/NEJM199809033391003.
10. Oral H, Scharf C, Chugh A, Hall B, Cheung P, Good E, Veerareddy S, Pelosi F, Jr, Morady F. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation. 2003;108:2355-2360. doi: 10.1161/01. CIR.0000095796.45180.88.
11. Tzou WS, Marchlinski FE, Zado ES, Lin D, Dixit S, Callans DJ, Cooper JM, Bala R, Garcia F, Hutchinson MD, Riley MP, Verdino R, Gerstenfeld EP. Long-term outcome after successful catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:237-242. doi: 10.1161/CIRCEP.109.923771.
12. Aytemir K, Oto A, Canpolat U, Sunman H, Yorgun H, ?ahiner L, Kaya EB. Immediate and medium-term outcomes of cryoballoon-based pulmonary vein isolation in patients with paroxysmal and persistent atrial fibrillation: single-centre experience. J Interv Card Electrophysiol. 2013;38:187-195. doi: 10.1007/s10840-013-9834-2.
13. Narayan SM, Krummen DE, Shivkumar K, Clopton P, Rappel WJ, Miller JM. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol. 2012;60:628-636. doi: 10.1016/j.jacc.2012.05.022.
14. Yorgun H, Aytemir K, Canpolat U, ?ahiner L, Kaya EB, Oto A. Additional benefit of cryoballoon-based atrial fibrillation ablation beyond pulmonary vein isolation: modification of ganglionated plexi. Europace. 2014;16:645-651. doi: 10.1093/europace/eut240.
15. Nakagawa H, Scherlag BJ, Patterson E, Ikeda A, Lockwood D, Jackman WM. Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation. Heart Rhythm. 2009;6(12 suppl):S26-S34. doi: 10.1016/j.hrthm.2009.07.029.
16. Fürnkranz A, Bordignon S, Dugo D, Perotta L, Gunawardene M, Schulte-Hahn B, Nowak B, Schmidt B, Chun JK. Improved 1-year clinical success rate of pulmonary vein isolation with the second-generation cryoballoon in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25:840-844. doi: 10.1111/jce.12417.
17. Metzner A, Rausch P, Lemes C, Reissmann B, Bardyszewski A, Tilz R, Rillig A, Mathew S, Deiss S, Kamioka M, Toennis T, Lin T, Ouyang F, Kuck KH, Wissner E. The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28 mm cryoballoon. J Cardiovasc Electrophysiol. 2014;25:466-470. doi: 10.1111/jce.12358.